Efficacy of levofloxacin as an antibacterial prophylaxis for acute leukemia patients receiving intensive chemotherapy: a systematic review and meta-analysis

References

• Kato H, Fujita H, Akiyama N, et al. Infectious complications in adults undergoing intensive chemotherapy for acute myeloid leukemia in 2001–2005 using the Japan Adult Leukemia Study Group AML201 protocols. Support Care Cancer. 2018; doi:10.1007/s00520-018-4292-0.
   Web of Science ®Google Scholar
• Kapoor R, Simalti AK, Roy S, et al. Clinicohematological profile of febrile neutropenia in childhood acute leukemia and Utility of serum procalcitonin levels in neutropenic patients. Indian J Crit Care Med. 2018;22:336–339. doi: 10.4103/ijccm.IJCCM_516_17
   PubMed Web of Science ®Google Scholar
• Di Blasi R, Cattaneo C, Lewis RE, et al. Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL). Ann Hematol. 2018;97:791–798. doi: 10.1007/s00277-018-3252-6
   PubMed Web of Science ®Google Scholar
• De Rosa FG, Motta I, Audisio E, et al. Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis. BMC Infect Dis. 2013; doi:10.1186/1471-2334-13-563.
   PubMed Web of Science ®Google Scholar
• Saito T, Yoshioka S, Iinuma Y, et al. Effects on spectrum and susceptibility patterns of isolates causing bloodstream infection by restriction of fluoroquinolone prophylaxis in a hematology-oncology unit. Eur J Clin Microbiol Infect Dis. 2008;27:209–216. doi: 10.1007/s10096-007-0428-8
   PubMed Web of Science ®Google Scholar
• Chong Y, Yakushiji H, Ito Y, et al. Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies. Int J Infect Dis. 2011;15:e277–e281. doi: 10.1016/j.ijid.2010.12.010
   PubMed Web of Science ®Google Scholar
• Sohn BS, Yoon DH, Kim S, et al. The role of prophylactic antimicrobials during autologous stem cell transplantation: a single-center experience. Eur J Clin Microbiol Infect Dis. 2012;31:1653–1661. doi: 10.1007/s10096-011-1489-2
   PubMed Web of Science ®Google Scholar
• Flowers CR, Seidenfeld J, Bow EJ, et al. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy. J Clin Oncol. 2013;31:794–810. doi: 10.1200/JCO.2012.45.8661
   PubMed Web of Science ®Google Scholar
• Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2011;52:e56–e93. doi: 10.1093/cid/cir073
   PubMed Web of Science ®Google Scholar
• Harris AD, Perencevich EN, Johnson JK, et al. Patient-to-patient transmission is important in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae acquisition. Clin Infect Dis. 2007;45:1347–1350. doi: 10.1086/522657
   PubMed Web of Science ®Google Scholar
• Lautenbach E, Metlay JP, Bilker WB, et al. Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy. Clin Infect Dis. 2005;41:923–929. doi: 10.1086/432065
   PubMed Web of Science ®Google Scholar
• Prabhu RM, Piper KE, Litzow MR, et al. Emergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxis. Eur J Clin Microbiol Infect Dis. 2005;24:832–838. doi: 10.1007/s10096-005-0037-3
   PubMed Web of Science ®Google Scholar
• Muto CA, Pokrywka M, Shutt K, et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol. 2005;26:273–280. doi: 10.1086/502539
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Br Med J. 2009;doi: 10.1136/bmj.b2535
   Web of Science ®Google Scholar
• Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12. doi: 10.1016/0197-2456(95)00134-4
   PubMedGoogle Scholar
• Stang A. Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–605. doi: 10.1007/s10654-010-9491-z
   PubMed Web of Science ®Google Scholar
• Borenstein M, Hedges LV, Higgins JPT, et al. Introduction to meta-analysis. West Sussex: John Wiley & Sons; 2009.
   Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. Br Med J. 2003;327:557–560. doi: 10.1136/bmj.327.7414.557
   PubMed Web of Science ®Google Scholar
• Bucaneve G, Micozzi A, Menichetti F, et al. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med. 2005;353:977–987. doi: 10.1056/NEJMoa044097
   PubMed Web of Science ®Google Scholar
• Rahman MM, Khan MA. Levofloxacin prophylaxis to prevent bacterial infection in chemotherapy-induced neutropenia in acute leukemia. Bangladesh Med Res Counc Bull. 2009;35:91–94. doi: 10.3329/bmrcb.v35i3.4130
   PubMedGoogle Scholar
• Ganti BR, Marini BL, Nagel J, et al. Impact of antibacterial prophylaxis during reinduction chemotherapy for relapse/refractory acute myeloid leukemia. Support Care Cancer. 2017;25:541–547. doi: 10.1007/s00520-016-3436-3
   PubMed Web of Science ®Google Scholar
• Wolf J, Tang L, Flynn PM, et al. Levofloxacin prophylaxis during induction therapy for pediatric acute lymphoblastic leukemia. Clin Infect Dis. 2017;65:1790–1798. doi: 10.1093/cid/cix644
   PubMed Web of Science ®Google Scholar
• Lee SSF, Fulford AE, Quinn MA, et al. Levofloxacin for febrile neutropenia prophylaxis in acute myeloid leukemia patients associated with reduction in hospital admissions. Support Care Cancer. 2018;26:1499–1504.
   PubMed Web of Science ®Google Scholar
• Mikulsa M, Averbuch D, Tissot F, et al. Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines. J Infect. 2018;76:20–37. doi: 10.1016/j.jinf.2017.10.009
   PubMed Web of Science ®Google Scholar